Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS Coronavirus (SARS-CoV-2) Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT06181292
What this trial is testing

Safety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine

Who this might be right for
SARS-CoV2 Infection
Hipra Scientific, S.L.U 913
Very early researchUnknownNCT06272253
What this trial is testing

UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent Subjects

Who this might be right for
COVID-19 PandemicCOVID-19 Vaccines
Dr. Soetomo General Hospital 250
Large-scale testing (Phase 3)Study completedNCT04380519
What this trial is testing

Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)

Who this might be right for
COVID-19
R-Pharm International, LLC 372
Early research (Phase 1)Study completedNCT05844202
What this trial is testing

Safety, Tolerability and Immunogenicity of Alveavax-v1.2, a BA.2/Omicron-optimized, DNA Vaccine for COVID-19 Prevention

Who this might be right for
Sars-CoV-2 Infection
Alvea Holdings, LLC 130
Not applicableStudy completedNCT04601012
What this trial is testing

OCTA Study: Retinal Vascular Changes in Patients With SARS-CoV-2 Infection

Who this might be right for
Covid19
Federico II University 40
Post-approval studies (Phase 4)UnknownNCT04912011
What this trial is testing

Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19.

Who this might be right for
COVID-19 Pneumonia
Pomeranian Medical University Szczecin 50
Not applicableStudy completedNCT05477394
What this trial is testing

Metabolic Syndrome as Prognostic Factor for Outcome of Sever SARS-COV-2 Cases.

Who this might be right for
COVID-19
Ain Shams University 90
Large-scale testing (Phase 3)UnknownNCT04954092
What this trial is testing

Study of Gam-COVID-Vac in Adolescents

Who this might be right for
Covid19Vaccine Preventable Disease
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 3,000
Testing effectiveness (Phase 2)Ended earlyNCT04344951
What this trial is testing

Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial

Who this might be right for
Pneumonia, ViralCovid-19
Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. 29
Not applicableWithdrawnNCT04251767
What this trial is testing

Washed Microbiota Transplantation for Patients With 2019-nCoV Infection

Who this might be right for
COVID-19 Complicated With Refractory Intestinal Infections
The Second Hospital of Nanjing Medical University
Large-scale testing (Phase 3)Ended earlyNCT05683600
What this trial is testing

Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd. 3,000
Not applicableStudy completedNCT05104411
What this trial is testing

Rehabilitation in Severely Ill Inpatients With COVID-19

Who this might be right for
COVID-19
Seoul National University Bundang Hospital 37
Large-scale testing (Phase 3)UnknownNCT05172037
What this trial is testing

Novaferon in Non-hospitalized Adult Patients With Mild COVID-19

Who this might be right for
Covid19
Genova Inc. 222
Not applicableStudy completedNCT04568707
What this trial is testing

Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES)

Who this might be right for
Covid19Neurologic ManifestationsPsychiatric Manifestations
Assistance Publique - Hôpitaux de Paris 238
Not applicableUnknownNCT05514522
What this trial is testing

The UK Interstitial Lung Disease Long-COVID19 Study (UKILD-Long COVID): Understanding the Burden of Interstitial Lung Disease in Long COVID.

Who this might be right for
Interstitial Lung DiseaseSARS-CoV-2 Infection
Imperial College London 2,000
Not applicableUnknownNCT04444401
What this trial is testing

Registry on NEN Patients and COVID-19

Who this might be right for
Neuroendocrine TumorsCOVID-19
European Institute of Oncology 50
Not applicableUnknownNCT04452773
What this trial is testing

Clinical Trial to Evaluate the Efficacy of Food Supplement Manremyc® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers

Who this might be right for
COVID19
Reig Jofre Group 315
Large-scale testing (Phase 3)Study completedNCT04649151
What this trial is testing

Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 4,328
Not applicableLooking for participantsNCT06099795
What this trial is testing

Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2

Who this might be right for
SARS-CoV-2 InfectionCOVID-19Coronavirus
Centre Hospitalier Universitaire de Nīmes 250
Testing effectiveness (Phase 2)Study completedNCT04761822
What this trial is testing

COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations

Who this might be right for
SARS-CoV InfectionCOVID-19Allergic Reaction+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 746
Next Page